Delphia (USA)’s Hologic HOLX Stock Holding History

Delphia (USA)’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,322	Closed	-$369K	–	343
2022 Q2	$369K	Buy	5,322 +156	+3%	+$11.6K	0.25%	136
2022 Q1	$397K	Buy	+5,166	New	+$371K	0.3%	117

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Delphia (USA)'s HOLX Position: Q3 2022 in Review

Delphia (USA) sold out of Hologic (HOLX) in Q3 2022, closing a stake of 5,322 shares — an estimated $369K sold.

Delphia (USA) first reported a position in HOLX in Q1 2022 and held it in 2 quarters. The position peaked at $397K in Q1 2022. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

Delphia (USA) reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
Delphia (USA) sold 5,322 Hologic shares in Q3 2022, an estimated $369K.
Delphia (USA) first reported a position in Hologic in Q1 2022 and held it in 2 quarters.
Delphia (USA)'s Hologic position peaked at $397K in Q1 2022.
654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.